Substance / Medication

Glucose

Overview

Active Ingredient
glucose
RxNorm CUI
4850

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

44 trials linked to this intervention

44
Total Trials
4
Recruiting
5
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Glucose Testing Methods: A Systematic Review and Meta-Analysis of Diagnostic Accuracy of Point-of-Care Devices for Neonatal Hypoglycemia.
St Clair Sophie L, Ulyatt Caitlyn M, Corkin Maria T et al. · J Pediatr · 2025
PMID: 39675663Meta-Analysis
Genomic insights about the effect of sodium-glucose cotransporter 2 inhibitors: a systematic review.
Saravana Kumar Pavitraa, Chidambaram Yogapriya, Shree Devi G et al. · Front Genet · 2025
PMID: 40520225Meta-AnalysisFull text (PMC)
New-onset glucose disorders in peritoneal dialysis patients: a meta-analysis and systematic review.
Xue Cheng, Gu Yan-Yan, Cui Cheng-Ji et al. · Nephrol Dial Transplant · 2020
PMID: 31236586Meta-Analysis
Effects of sodium-glucose cotransporter 2 inhibitors on risk of venous thromboembolism in patients with type 2 diabetes: A systematic review and meta-analysis.
Wang Aihua, Yang Keming, Wang Tiansheng et al. · Diabetes Metab Res Rev · 2020
PMID: 31050384Meta-Analysis
Sodium-glucose co-transporter 2 inhibitors for the prevention of heart failure in type 2 diabetes: A systematic review and meta-analysis.
Yamani Naser, Usman Muhammad Shariq, Akhtar Tauseef et al. · Eur J Prev Cardiol · 2020
PMID: 30966822Meta-Analysis
The healthy Nordic diet for blood glucose control: a systematic review and meta-analysis of randomized controlled clinical trials.
Zimorovat Alireza, Mohammadi Mohammad, Ramezani-Jolfaie Nahid et al. · Acta Diabetol · 2020
PMID: 31172295Meta-Analysis
The Relationship Between Tumor Glucose Metabolism and Host Systemic Inflammatory Responses in Patients with Cancer: A Systematic Review.
Dolan Ross D, McLees Naomi G, Irfan Ahmer et al. · J Nucl Med · 2019
PMID: 30166353Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Glucose (substance)
SNOMED CT
67079006
UMLS CUI
C0017725
RxNorm CUI
4850

Clinical Data

This intervention maps to 5 entities in the Ltrl knowledge graph.

4
Conditions
1
Biomarkers
0
Specialists
0
Symptoms
44
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.